Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
PErsonalized Addition of Recombinant LH in Ovarian Stimulation (PEARL)

Different ovarian stimulation regimens have shown to modify late follicular phase hormonal profiles. Besides, recent studies confirm that progesterone levels and their variation in the last day

estradiol
progesterone
crinone
gonal-f
estrogen
  • 1 views
  • 11 Mar, 2022
  • 1 location
Comparison of Triggers in Double Ovarian Stimulation (DuoStim). (COTRID)

This study aims to investigate the efficacy of 3 different trigggers used for final maturation in the second ovarian stimulation in double stimulation protocol (aGnRH and hCG-rec vs. aGnRH only

Accepts healthy volunteers
  • 0 views
  • 23 Apr, 2022
  • 4 locations
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders (MONACO)

This is a prospective, randomized, single center, phase 4 controlled trial. The study will compare the efficacy of two different strategies for the management of predicted poor response patients under stimulation for IVF/ICSI: up to three MNC cycles (group 1) versus a single GnRH antagonist CFA (group 2).

  • 0 views
  • 10 Apr, 2022
  • 1 location
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis (APPOSE)

Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pregnancy rates.

endometrioma
Accepts healthy volunteers
letrozole
surgical diagnosis
endometriosis
  • 207 views
  • 24 Feb, 2022
  • 1 location
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors (RANDOS)

Oocyte donation is a cumbersome and demanding procedure, involving an injectable hormonal treatment for an average duration of 12 days, according to the protocols, 1 to several daily injections. The objective of this study is to show that treatments can be simplified without reducing the number of oocytes that have …

regular menstrual cycles
antral
ovarian stimulation
progesterone
gonadotropin
  • 257 views
  • 08 Jun, 2022
  • 5 locations
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

To demonstrate non-inferiority of FE 999049 compared with GONAL-F with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation.

transvaginal ultrasound
oocyte retrieval
hydrosalpinx
uterine fibroids
follicle stimulating hormone
  • 0 views
  • 07 Oct, 2022
  • 10 locations
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation (ADAPT-1)

Hormone preparations like REKOVELLE and GONAL-F are used to make the body produce multiple egg sacs, allowing more eggs to be collected from women undergoing infertility treatment. The main purpose of this trial is to see how many eggs are produced with a starting dose of 15 µg REKOVELLE compared …

regular menstrual cycles
in vitro fertilization
infertility treatment
gonal-f
follitropin alfa
  • 0 views
  • 04 Oct, 2022
  • 1 location
Prospective, Randomized Trial Comparing Luteal Phase Ovarian Stimulation, and Luteal Estradiol Priming Protocol for Patients With Diminished Ovarian Reserve - The LUTEAL Trial

population. The ovarian response to controlled ovarian stimulation with gonadotropins (for example, for in vitro fertilization) is largely determined by the ovarian reserve, and there are numerous

infertility
regular menstrual cycles
estradiol
antral
anti-mullerian hormone
  • 598 views
  • 28 Oct, 2022
  • 1 location
  • 0 views
  • 22 Oct, 2022
A Randomized Control Trial to Investigate the Effect of Growth Hormone on the Euploid Rate of Blastocyst in Patients With Advanced Maternal Age

randomised into one of the two groups: Treatment group: Women will receive growth hormone (GH) supplement before and during antagonist protocol for ovarian stimulation. Control group: Women

  • 0 views
  • 28 Oct, 2022
  • 1 location